Ligand Pharmaceuticals General Stock Price Prediction

LGNYZ Stock  USD 0.01  0.00  0.00%   
At this time, the relative strength index (RSI) of Ligand Pharmaceuticals' share price is approaching 39. This indicates that the pink sheet is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Ligand Pharmaceuticals, making its price go up or down.

Oversold Vs Overbought

39

 
Oversold
 
Overbought
Ligand Pharmaceuticals stock price prediction is an act of determining the future value of Ligand Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Ligand Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Ligand Pharmaceuticals and does not consider all of the tangible or intangible factors available from Ligand Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Ligand Pharmaceuticals General, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether pink sheet price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Ligand Pharmaceuticals based on different types of headlines from major news networks to social media. The Ligand stock price prediction module provides an analysis of price elasticity to changes in media outlook on Ligand Pharmaceuticals over a specific investment horizon. Using Ligand Pharmaceuticals hype-based prediction, you can estimate the value of Ligand Pharmaceuticals General from the perspective of Ligand Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Ligand Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Ligand Pharmaceuticals to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Ligand because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Ligand Pharmaceuticals after-hype prediction price

    
  USD 0.008704  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ligand Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.010.010.01
Details
Naive
Forecast
LowNextHigh
0.010.010.01
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
00.010.01
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Ligand Pharmaceuticals. Your research has to be compared to or analyzed against Ligand Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Ligand Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Ligand Pharmaceuticals.

Ligand Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Ligand Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ligand Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Ligand Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Ligand Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Ligand Pharmaceuticals' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ligand Pharmaceuticals' historical news coverage. Ligand Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.01 and 0.01, respectively. We have considered Ligand Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.01
0.01
After-hype Price
0.01
Upside
Ligand Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Ligand Pharmaceuticals is based on 3 months time horizon.

Ligand Pharmaceuticals Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Ligand Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ligand Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ligand Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
0 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.01
0.01
36.00 
0.00  
Notes

Ligand Pharmaceuticals Hype Timeline

Ligand Pharmaceuticals is now traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Ligand is anticipated to increase in value after the next headline, with the price projected to jump to 0.008704 or above. The average volatility of media hype impact on the company the price is insignificant. The price jump on the next news is estimated to be 36.0%, whereas the daily expected return is now at 0.0%. The volatility of related hype on Ligand Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.01. Debt can assist Ligand Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Ligand Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ligand Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ligand to invest in growth at high rates of return. When we think about Ligand Pharmaceuticals' use of debt, we should always consider it together with cash and equity.Assuming the 90 days horizon the next anticipated press release will be uncertain.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

Ligand Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Ligand Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Ligand Pharmaceuticals' future price movements. Getting to know how Ligand Pharmaceuticals rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ligand Pharmaceuticals may potentially react to the hype associated with one of its peers.

Ligand Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Ligand price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ligand using various technical indicators. When you analyze Ligand charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Ligand Pharmaceuticals Predictive Indicators

The successful prediction of Ligand Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ligand Pharmaceuticals General, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ligand Pharmaceuticals based on analysis of Ligand Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ligand Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ligand Pharmaceuticals's related companies.

Story Coverage note for Ligand Pharmaceuticals

The number of cover stories for Ligand Pharmaceuticals depends on current market conditions and Ligand Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ligand Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ligand Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Ligand Pharmaceuticals Short Properties

Ligand Pharmaceuticals' future price predictability will typically decrease when Ligand Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ligand Pharmaceuticals General often depends not only on the future outlook of the potential Ligand Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ligand Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Cash And Short Term Investments341.1 M
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Ligand Pink Sheet analysis

When running Ligand Pharmaceuticals' price analysis, check to measure Ligand Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ligand Pharmaceuticals is operating at the current time. Most of Ligand Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ligand Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ligand Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ligand Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Please note, there is a significant difference between Ligand Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ligand Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ligand Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.